Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rilpivirine Tablets

Approval Number

国药准字H20244840

Company瑞阳制药股份有限公司

Registration Date

September 10, 2024

Drug Information

Generic Name

利匹韦林片

Dosage Form

片剂

Strength

25mg（按C₂₂H₁₈N₆计）

Drug Type

化学药品

Registration Date

September 10, 2024

Company Information

Applicant Company

Company Name瑞阳制药股份有限公司

Company Address

山东省沂源县城瑞阳路1号

Manufacturing Company

Company Name瑞阳制药股份有限公司

Company Address

山东省沂源县城瑞阳路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利匹韦林片 - NMPA 批准文号 | MedPath